Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) subsidiary MindWave Innovations Inc. has entered into a 12-month technology services agreement with Singapore-based AQUAE Holdings Pte. Ltd. to deploy its MindChain infrastructure as the foundation of AQUAEChain, a platform for insured ALCI Credits. The announcement, issued via TechMediaWire, outlines that MindWave will design, develop, deploy and host AQUAEChain, which will manage the issuance, verification, tracking, transfer and retirement of ALCI Credits. MindWave will also provide ongoing technical support and receive contracted software development and technology service fees.
In addition to service fees, the agreement includes an allocation to MindWave equal to 20% of total ALCI Credits issued and outstanding on the AQUAEChain network, calculated quarterly using the MindChain issuance ledger. This structure ties MindWave's compensation to the success of the platform. Following the initial 12-month term, the parties expect to transition to a five-year continuing technology services arrangement, subject to mutual agreement and definitive documentation. The full press release can be viewed at https://ibn.fm/eZCn1.
MindWave Innovations, a wholly owned subsidiary of Apimeds Pharmaceuticals US, is developing enterprise blockchain infrastructure and institutional technology platforms through its MindChain ecosystem. Four ecosystems operate under MindChain: InsurTech through BlockAssure, which is developing a Bermuda-framework platform applying Bitcoin reserves as regulatory capital to support life and property and casualty underwriting; ClimateTech through AQUAE and the ALCI index, measuring, verifying and tokenizing ecosystem services into institutional-grade assets; HealthTech through the Apitox development program; and RWA Tech through Nexus Global Partners, bringing institutional real estate on-chain within a compliance-first, insurance-enhanced framework. Apimeds Pharmaceuticals US is a clinical-stage biopharmaceutical company focused on developing non-opioid, biologic-based therapies for pain management. For more information, visit www.ApimedsUS.com.
The agreement matters because it represents a significant step in the commercialization of MindWave's blockchain infrastructure, particularly in the ClimateTech space where tokenization of ecosystem services is gaining traction. By providing the technological backbone for AQUAEChain, MindWave positions itself at the intersection of blockchain, insurance, and environmental assets. The 20% credit allocation could provide ongoing value if ALCI Credits see widespread adoption. Moreover, the potential five-year extension suggests confidence in a long-term partnership, which could lead to recurring revenue and further validation of MindChain's capabilities. Investors in APUS may view this as a diversification beyond biopharma, tapping into the growing demand for institutional-grade blockchain solutions. The latest updates on APUS are available at https://ibn.fm/APUS.
TechMediaWire, a specialized communications platform focused on pioneering companies driving the future of technology, is one of 75+ brands within the Dynamic Brand Portfolio at IBN. The platform delivers access to wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, and enhanced press release enhancement to ensure maximum impact. It also offers social media distribution and a full array of tailored corporate communications solutions. For full terms of use and disclaimers, see https://www.TechMediaWire.com/Disclaimer.
